Selected research
Industry Growth & Trends
Global Megestrol Acetate (Megace) Industry Growth and Trends Forecast to 2032
Market perspective
The global Megestrol Acetate (Megace) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Megestrol Acetate (Megace) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Megestrol Acetate (Megace) include Actiza Pharmaceutical, Apotex Corporation, Breckenridge Pharmaceutical, Hikma (West-ward Pharm, Roxane Labs..), Hi-tech Pharmacal (Akorn), Morton Grove Pharmaceutical, Par Pharmaceutical (Endo International), TWi Pharmaceuticals and Jiangsu Nhwa Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Megestrol Acetate (Megace) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Megestrol Acetate (Megace) market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Megestrol Acetate (Megace) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Megestrol Acetate (Megace).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Megestrol Acetate (Megace) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Megestrol Acetate (Megace) Market by Company
Actiza Pharmaceutical
Apotex Corporation
Breckenridge Pharmaceutical
Hikma (West-ward Pharm, Roxane Labs..)
Hi-tech Pharmacal (Akorn)
Morton Grove Pharmaceutical
Par Pharmaceutical (Endo International)
TWi Pharmaceuticals
Jiangsu Nhwa Pharmaceutical
Nanjing Cuccess Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Teva Pharmaceuticals
Grand Deten Pharmaceutical
Xianju pharma
Megestrol Acetate (Megace) Segment by Type
Suspension
Tablets
Megestrol Acetate (Megace) Segment by Application
Hospital
Clinic
Other
Megestrol Acetate (Megace) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol Acetate (Megace) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Megestrol Acetate (Megace) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol Acetate (Megace).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Megestrol Acetate (Megace) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Suspension
- Tablets
Applications
- Hospital
- Clinic
- Other
Companies covered
- Actiza Pharmaceutical
- Apotex Corporation
- Breckenridge Pharmaceutical
- Hikma (West-ward Pharm, Roxane Labs..)
- Hi-tech Pharmacal (Akorn)
- Morton Grove Pharmaceutical
- Par Pharmaceutical (Endo International)
- TWi Pharmaceuticals
- Jiangsu Nhwa Pharmaceutical
- Nanjing Cuccess Pharmaceutical
- Qingdao Guohai Biological Pharmaceutical
- Teva Pharmaceuticals
- Grand Deten Pharmaceutical
- Xianju pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Megestrol Acetate (Megace) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Megestrol Acetate (Megace) Sales Estimates and Forecasts (2021-2032)
- 1.3 Megestrol Acetate (Megace) Market by Type
- 1.3.1 Suspension
- 1.3.2 Tablets
- 1.4 Global Megestrol Acetate (Megace) Market Size by Type
- 1.4.1 Global Megestrol Acetate (Megace) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Megestrol Acetate (Megace) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Megestrol Acetate (Megace) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Megestrol Acetate (Megace) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Megestrol Acetate (Megace) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Megestrol Acetate (Megace) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Megestrol Acetate (Megace) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Megestrol Acetate (Megace) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Megestrol Acetate (Megace) Industry Trends
- 2.2 Megestrol Acetate (Megace) Industry Drivers
- 2.3 Megestrol Acetate (Megace) Industry Opportunities and Challenges
- 2.4 Megestrol Acetate (Megace) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Megestrol Acetate (Megace) Revenue (2021-2026)
- 3.2 Global Top Players by Megestrol Acetate (Megace) Sales (2021-2026)
- 3.3 Global Top Players by Megestrol Acetate (Megace) Price (2021-2026)
- 3.4 Global Megestrol Acetate (Megace) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Megestrol Acetate (Megace) Major Company Production Sites & Headquarters
- 3.6 Global Megestrol Acetate (Megace) Company, Product Type & Application
- 3.7 Global Megestrol Acetate (Megace) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Megestrol Acetate (Megace) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Megestrol Acetate (Megace) Players Market Share by Revenue in 2025
- 3.8.3 2025 Megestrol Acetate (Megace) Tier 1, Tier 2, and Tier 3
4 Megestrol Acetate (Megace) Regional Status and Outlook
- 4.1 Global Megestrol Acetate (Megace) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Megestrol Acetate (Megace) Historic Market Size by Region
- 4.2.1 Global Megestrol Acetate (Megace) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Megestrol Acetate (Megace) Sales in Value by Region (2021-2026)
- 4.2.3 Global Megestrol Acetate (Megace) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Megestrol Acetate (Megace) Forecasted Market Size by Region
- 4.3.1 Global Megestrol Acetate (Megace) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Megestrol Acetate (Megace) Sales in Value by Region (2027-2032)
- 4.3.3 Global Megestrol Acetate (Megace) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Megestrol Acetate (Megace) by Application
- 5.1 Megestrol Acetate (Megace) Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Megestrol Acetate (Megace) Market Size by Application
- 5.2.1 Global Megestrol Acetate (Megace) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Megestrol Acetate (Megace) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Megestrol Acetate (Megace) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Megestrol Acetate (Megace) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Megestrol Acetate (Megace) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Megestrol Acetate (Megace) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Megestrol Acetate (Megace) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Megestrol Acetate (Megace) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Actiza Pharmaceutical
- 6.1.1 Actiza Pharmaceutical Company Information
- 6.1.2 Actiza Pharmaceutical Business Overview
- 6.1.3 Actiza Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.1.5 Actiza Pharmaceutical Recent Developments
- 6.2 Apotex Corporation
- 6.2.1 Apotex Corporation Company Information
- 6.2.2 Apotex Corporation Business Overview
- 6.2.3 Apotex Corporation Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Apotex Corporation Megestrol Acetate (Megace) Product Portfolio
- 6.2.5 Apotex Corporation Recent Developments
- 6.3 Breckenridge Pharmaceutical
- 6.3.1 Breckenridge Pharmaceutical Company Information
- 6.3.2 Breckenridge Pharmaceutical Business Overview
- 6.3.3 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.3.5 Breckenridge Pharmaceutical Recent Developments
- 6.4 Hikma (West-ward Pharm, Roxane Labs..)
- 6.4.1 Hikma (West-ward Pharm, Roxane Labs..) Company Information
- 6.4.2 Hikma (West-ward Pharm, Roxane Labs..) Business Overview
- 6.4.3 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio
- 6.4.5 Hikma (West-ward Pharm, Roxane Labs..) Recent Developments
- 6.5 Hi-tech Pharmacal (Akorn)
- 6.5.1 Hi-tech Pharmacal (Akorn) Company Information
- 6.5.2 Hi-tech Pharmacal (Akorn) Business Overview
- 6.5.3 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio
- 6.5.5 Hi-tech Pharmacal (Akorn) Recent Developments
- 6.6 Morton Grove Pharmaceutical
- 6.6.1 Morton Grove Pharmaceutical Company Information
- 6.6.2 Morton Grove Pharmaceutical Business Overview
- 6.6.3 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.6.5 Morton Grove Pharmaceutical Recent Developments
- 6.7 Par Pharmaceutical (Endo International)
- 6.7.1 Par Pharmaceutical (Endo International) Company Information
- 6.7.2 Par Pharmaceutical (Endo International) Business Overview
- 6.7.3 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio
- 6.7.5 Par Pharmaceutical (Endo International) Recent Developments
- 6.8 TWi Pharmaceuticals
- 6.8.1 TWi Pharmaceuticals Company Information
- 6.8.2 TWi Pharmaceuticals Business Overview
- 6.8.3 TWi Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 6.8.5 TWi Pharmaceuticals Recent Developments
- 6.9 Jiangsu Nhwa Pharmaceutical
- 6.9.1 Jiangsu Nhwa Pharmaceutical Company Information
- 6.9.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 6.9.3 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.9.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 6.10 Nanjing Cuccess Pharmaceutical
- 6.10.1 Nanjing Cuccess Pharmaceutical Company Information
- 6.10.2 Nanjing Cuccess Pharmaceutical Business Overview
- 6.10.3 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.10.5 Nanjing Cuccess Pharmaceutical Recent Developments
- 6.11 Qingdao Guohai Biological Pharmaceutical
- 6.11.1 Qingdao Guohai Biological Pharmaceutical Company Information
- 6.11.2 Qingdao Guohai Biological Pharmaceutical Business Overview
- 6.11.3 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.11.5 Qingdao Guohai Biological Pharmaceutical Recent Developments
- 6.12 Teva Pharmaceuticals
- 6.12.1 Teva Pharmaceuticals Company Information
- 6.12.2 Teva Pharmaceuticals Business Overview
- 6.12.3 Teva Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
- 6.12.5 Teva Pharmaceuticals Recent Developments
- 6.13 Grand Deten Pharmaceutical
- 6.13.1 Grand Deten Pharmaceutical Company Information
- 6.13.2 Grand Deten Pharmaceutical Business Overview
- 6.13.3 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
- 6.13.5 Grand Deten Pharmaceutical Recent Developments
- 6.14 Xianju pharma
- 6.14.1 Xianju pharma Company Information
- 6.14.2 Xianju pharma Business Overview
- 6.14.3 Xianju pharma Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Xianju pharma Megestrol Acetate (Megace) Product Portfolio
- 6.14.5 Xianju pharma Recent Developments
7 North America by Country
- 7.1 North America Megestrol Acetate (Megace) Sales by Country
- 7.1.1 North America Megestrol Acetate (Megace) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Megestrol Acetate (Megace) Sales by Country (2021-2026)
- 7.1.3 North America Megestrol Acetate (Megace) Sales Forecast by Country (2027-2032)
- 7.2 North America Megestrol Acetate (Megace) Market Size by Country
- 7.2.1 North America Megestrol Acetate (Megace) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Megestrol Acetate (Megace) Market Size by Country (2021-2026)
- 7.2.3 North America Megestrol Acetate (Megace) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Megestrol Acetate (Megace) Sales by Country
- 8.1.1 Europe Megestrol Acetate (Megace) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Megestrol Acetate (Megace) Sales by Country (2021-2026)
- 8.1.3 Europe Megestrol Acetate (Megace) Sales Forecast by Country (2027-2032)
- 8.2 Europe Megestrol Acetate (Megace) Market Size by Country
- 8.2.1 Europe Megestrol Acetate (Megace) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Megestrol Acetate (Megace) Market Size by Country (2021-2026)
- 8.2.3 Europe Megestrol Acetate (Megace) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Megestrol Acetate (Megace) Sales by Country
- 9.1.1 Asia-Pacific Megestrol Acetate (Megace) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Megestrol Acetate (Megace) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Megestrol Acetate (Megace) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Megestrol Acetate (Megace) Market Size by Country
- 9.2.1 Asia-Pacific Megestrol Acetate (Megace) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Megestrol Acetate (Megace) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Megestrol Acetate (Megace) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Megestrol Acetate (Megace) Sales by Country
- 10.1.1 South America Megestrol Acetate (Megace) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Megestrol Acetate (Megace) Sales by Country (2021-2026)
- 10.1.3 South America Megestrol Acetate (Megace) Sales Forecast by Country (2027-2032)
- 10.2 South America Megestrol Acetate (Megace) Market Size by Country
- 10.2.1 South America Megestrol Acetate (Megace) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Megestrol Acetate (Megace) Market Size by Country (2021-2026)
- 10.2.3 South America Megestrol Acetate (Megace) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Megestrol Acetate (Megace) Sales by Country
- 11.1.1 Middle East and Africa Megestrol Acetate (Megace) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Megestrol Acetate (Megace) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Megestrol Acetate (Megace) Market Size by Country
- 11.2.1 Middle East and Africa Megestrol Acetate (Megace) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Megestrol Acetate (Megace) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Megestrol Acetate (Megace) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Megestrol Acetate (Megace) Value Chain Analysis
- 12.1.1 Megestrol Acetate (Megace) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Megestrol Acetate (Megace) Production Mode & Process
- 12.2 Megestrol Acetate (Megace) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Megestrol Acetate (Megace) Distributors
- 12.2.3 Megestrol Acetate (Megace) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst